特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
786008

肝臓癌診断市場規模、シェア、動向分析レポート:スクリーニングタイプ別(生検、内視鏡検査、試験所検査、画像)、地域別(北米、アジア太平洋地域、欧州)セグメント予測

Liver Cancer Diagnostic Market Size, Share & Trends Analysis Report By Screening Type (Biopsy, Endoscopy, Laboratory Tests, Imaging), By Region (North America, APAC, Europe), And Segment Forecasts, 2019 - 2025

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 111 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
肝臓癌診断市場規模、シェア、動向分析レポート:スクリーニングタイプ別(生検、内視鏡検査、試験所検査、画像)、地域別(北米、アジア太平洋地域、欧州)セグメント予測
出版日: 2019年01月18日
発行: Grand View Research, Inc.
ページ情報: 英文 111 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の肝臓癌診断市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、範囲

第4章 業界見通し

  • 市場変数分析
  • 市場阻害因子分析

第5章 ビジネス環境分析

  • SWOT分析
  • ポーターズファイブフォース分析

第6章 スクリーニングタイプ別ビジネス分析

  • 動向分析
  • 試験所検査
  • バイオマーカー検査
  • 画像
  • 内視鏡検査
  • 生検
  • その他

第7章 地域別ビジネス分析

  • 動向分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 企業プロファイル

  • Abbott Laboratories
  • Roche Diagnostics
  • Qiagen
  • Siemens Healthineers
  • Thermo Fischer Scientific Inc.
  • Hologic
  • Becton, Dickinson and Company
  • Sirtex Medical ltd.
  • Koninklijke Philips N.V.
  • Illumina,Inc.
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America liver cancer diagnostics market, by region, 2014 - 2025 (USD Million)
  • Table 3 North America liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 4 North America liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 5 North America liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 6 North America liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 7 U.S. liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 8 U.S. liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 9 U.S. liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 10 U.S. liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 11 Canada liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 12 Canada liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 13 Canada liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 14 Canada liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 15 Europe liver cancer diagnostics market, by region, 2014 - 2025 (USD Million)
  • Table 16 Europe liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 17 Europe liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 18 Europe liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 19 Europe liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 20 U.K. liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 21 U.K. liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 22 U.K. liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 23 U.K. liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 24 Germany liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 25 Germany liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 26 Germany liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 27 Germany liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 28 Asia Pacific liver cancer diagnostics market, by region, 2014 - 2025 (USD Million)
  • Table 29 Asia Pacific liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 30 ASIA Pacific liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 31 Asia Pacific liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 32 Asia Pacific liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 33 China liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 34 China liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 35 China liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 36 China liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 37 Japan liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 38 Japan liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 39 Japan liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 40 Japan liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 41 Latin America liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 42 Latin America liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 43 Latin America liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 44 Latin America liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 45 Mexico liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 46 Mexico liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 47 Mexico liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 48 Mexico liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 49 Brazil liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 50 Brazi liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 51 Brazil liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 52 Brazil liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 53 MEA liver cancer diagnostics market, by region, 2014 - 2025 (USD Million)
  • Table 54 MEA liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 55 MEA liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 56 MEA liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 57 MEA liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)
  • Table 58 Saudi Arabia liver cancer diagnostics market, by screening type, 2014 - 2025 (USD Million)
  • Table 59 Saudi Arabia liver cancer diagnostics market, by laboratory type, 2014 - 2025 (USD Million)
  • Table 60 Saudi Arabia liver cancer diagnostics biomarkers market, by type, 2014 - 2025 (USD Million)
  • Table 61 Saudi Arabia liver cancer diagnostics biomarkers market, by type, 2014 - 2025 ('000 units of screening)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Liver cancer diagnostics market snapshot
  • Fig. 8 Liver cancer diagnostics market segmentation
  • Fig. 9 Liver cancer diagnostics market driver impact
  • Fig. 10 Liver cancer diagnostics market driver impact
  • Fig. 11 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 Liver cancer diagnostics: Product outlook and key takeaways
  • Fig. 14 Liver cancer diagnostics: Type movement analysis
  • Fig. 15 Laboratory tests market estimates and forecast, 2014 - 2025
  • Fig. 16 Biomarker tests market estimates and forecast, 2014 - 2025
  • Fig. 17 Oncofetal and Glycoprotein market estimates and forecast, 2014 - 2025
  • Fig. 18 Enzymes and Isoenzymes market estimates and forecast, 2014 - 2025
  • Fig. 19 Growth factors and receptors market estimates and forecast, 2014 - 2025
  • Fig. 20 Molecular markers market estimates and forecast, 2014 - 2025
  • Fig. 21 Pathological Biomarkers market estimates and forecast, 2014 - 2025
  • Fig. 22 Blood tests market estimates and forecast, 2014 - 2025
  • Fig. 23 Imaging market estimates and forecast, 2014 - 2025
  • Fig. 24 Endoscopy markers market estimates and forecast, 2014 - 2025
  • Fig. 25 Biopsy market estimates and forecast, 2014 - 2025
  • Fig. 26 Others protein market estimates and forecast, 2014 - 2025
  • Fig. 27 Liver cancer diagnostics market: Regional outlook and key takeaways
  • Fig. 28 Liver cancer diagnostics market: Regional movement analysis
  • Fig. 29 North America
  • Fig. 30 North America market estimates and forecast, 2014 - 2025
  • Fig. 31 U.S. market estimates and forecast, 2014 - 2025
  • Fig. 32 Canada market estimates and forecast, 2014 - 2025
  • Fig. 33 Europe
  • Fig. 34 Europe market estimates and forecast, 2014 - 2025
  • Fig. 35 Germany market estimates and forecast, 2014 - 2025
  • Fig. 36 U.K. market estimates and forecast, 2014 - 2025
  • Fig. 37 Asia Pacific
  • Fig. 38 Asia pacific market estimates and forecast, 2014 - 2025
  • Fig. 39 Japan market estimates and forecast, 2014 - 2025
  • Fig. 40 China. market estimates and forecast, 2014 - 2025
  • Fig. 41 Australia market estimates and forecast, 2014 - 2025
  • Fig. 42 Latin America
  • Fig. 43 Latin America market estimates and forecast, 2014 - 2025
  • Fig. 44 Brazil market estimates and forecast, 2014 - 2025
  • Fig. 45 Mexico market estimates and forecast, 2014 - 2025
  • Fig. 46 Middle East & Africa
  • Fig. 47 Middle East & Africa market estimates and forecast, 2014 - 2025
  • Fig. 48 Saudi Arabia market estimates and forecast, 2014 - 2025
  • Fig. 49 South Africa market estimates and forecast, 2014 - 2025
目次
Product Code: GVR-3-68038-012-5

The global liver cancer diagnostics market size is expected to reach USD 15.4 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 8.1% over the estimated time period. Rise in disease incidence coupled with growing demand for novel diagnosis products are thrusting the growth of the market. Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer in adults. It is among the common causes of death in people with liver cirrhosis and the third-leading cause of cancer deaths across the globe. Poor survival rate and lack of therapies has made this disease a crucial health issue worldwide.

Government and some global health organizations are undertaking initiatives to raise awareness regarding liver cancer through various campaigns. These programs aim to create awareness about signs, symptoms, and complications associated with carcinomas. High costs associated with cancer treatments compared to other diseases have led to increasingly rigid treatment guidelines for expensive drugs and diagnostic tests across various markets. For instance, the Affordable Care Act, designed to improve quality of healthcare and reduce the cost associated with it. This act covers reimbursement for cancer diagnosis and treatment up to a certain extent. Governments in other countries are also taking efforts to overcome challenges, such as cost and access to cancer care.

Such efforts and insurance policies that cover cost of diagnosis and treatment of carcinomas are supporting market growth. Newer techniques developed for hepatocellular carcinoma render both liver transplant, as well as surgical resection, more effective and safer. Several etiological factors of HCC such as hepatitis infection and cirrhosis are modifiable and thus present a strong prospect to reduce disease mortality by preventive strategies. Key players and medical institutions are focusing on the development of advanced tests for HCC diagnosis. These factors along with high unmet needs are expected to propel the growth of liver cancer diagnostics market through the forecast period.

Further key findings from the study suggest:

Increasing awareness about liver cancer across the globe is expected to be the major factor driving the market growth

Laboratory tests emerged as the largest segment owing to increased demand for effective diagnostic tests for HCC

Oncofetal and Glucoprotein antigens accounted for the largest share in biomarkers segment

North America led the global liver cancer diagnostic market in 2017 and will maintain the dominance in future on account of rising awareness about early diagnosis and demand for novel diagnostic tests in the region

Illumina, Inc.; Qiagen; F. Hoffmann-La Roche Ltd.; Siemens Healthcare GmbH; and Thermo Fisher Scientific are some of the leading industry participants

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Research Methodology
    • 1.1.1 Information Procurement
  • 1.2 Information or Data Analysis
  • 1.3 Research Scope and Assumptions
  • 1.4 List to Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation

Chapter 4 Industry Outlook

  • 4.1 Market Variable Analysis
    • 4.1.1 Failure rate of conventional diagnosis
    • 4.1.2 Early detection leading to reduced healthcare costs
  • 4.2 Market Restraint Analysis
    • 4.2.1 High risk of radiation exposure and stringent regulatory guidelines
    • 4.2.2 High cost and unmet needs

Chapter 5 Business Environment Analysis

  • 5.1 SWOT Analysis; by factor (political & legal, economic and technological)
  • 5.2 Porter's five forces analysis

Chapter 6 Liver Cancer Diagnostics Market:Screening Type Business Analysis

  • 6.1 Liver Cancer Diagnostics: Type Movement Analysis
  • 6.2 Laboratory Tests
    • 6.2.1 Laboratory Tests market estimates and forecast, 2014 - 2025
  • 6.3 Biomarker Tests
    • 6.3.1 Biomarker Tests market estimates and forecast, 2014 - 2025
      • 6.3.1.1 Oncofetal And Glycoprotein Antigens
      • 6.3.1.1.1 Oncofetal And Glycoprotein Market Estimates And Forecast, 2014 - 2025
      • 6.3.1.2 Enzymes And Isoenzymes
      • 6.3.1.2.1 Enzymes And Isoenzymes Market Estimates And Forecast, 2014 - 2025
      • 6.3.1.3 Growth Factors And Receptors
      • 6.3.1.3.1 Growth Factors And Receptors Market Estimates And Forecast, 2014 - 2025
      • 6.3.1.4 Molecular Markers
      • 6.3.1.4.1 Molecular Markers Market Estimates And Forecast, 2014 - 2025
      • 6.3.1.5 Pathological Biomarkers
      • 6.3.1.5.1 Pathological Biomarkers Market Estimates And Forecast, 2014 - 2025
    • 6.3.2 Blood Tests
      • 6.3.2.1 Blood Tests Market Estimates And Forecast, 2014 - 2025
  • 6.4 Imaging
    • 6.4.1 Imaging Market Estimates And Forecast, 2014 - 2025
  • 6.5 Endoscopy
    • 6.5.1 Endoscopy Market Estimates And Forecast, 2014 - 2025
  • 6.6 Biopsy
    • 6.6.1 Biopsy Market Estimates And Forecast, 2014 - 2025
  • 6.7 Others
    • 6.7.1 Others Market Estimates And Forecast, 2014 - 2025

Chapter 7 Liver Cancer Diagnostics Market Regional Business Analysis

  • 7.1 Liver Cancer Diagnostics Market: Regional Movement Analysis
  • 7.2 North America
    • 7.2.1 North America market estimates and forecast, 2014 - 2025
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. market estimates and forecast, 2014 - 2025
    • 7.2.3 Canada
      • 7.2.3.1 Canada market estimates and forecast, 2014 - 2025
  • 7.3 Europe
    • 7.3.1 Europe market estimates and forecast, 2014 - 2025
    • 7.3.2 Germany
      • 7.3.2.1 Germany market estimates and forecast, 2014 - 2025
    • 7.3.3 U.K.
      • 7.3.3.1 U.K. market estimates and forecast, 2014 - 2025
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific market estimates and forecast, 2014 - 2025
    • 7.4.2 Japan
      • 7.4.2.1 Japan market estimates and forecast, 2014 - 2025
    • 7.4.3 China
      • 7.4.3.1 China market estimates and forecast, 2014 - 2025
  • 7.5 Latin America
    • 7.5.1 Brazil
      • 7.5.1.1 Brazil market estimates and forecast, 2014 - 2025
    • 7.5.2 Mexico
      • 7.5.2.1 Mexico market estimates and forecast, 2014 - 2025
  • 7.6 Middle East & Africa
    • 7.6.1 Middle East And Africa market estimates and forecast, 2014 - 2025
    • 7.6.2 Saudi Arabia
      • 7.6.2.1 Saudi Arabia market estimates and forecast, 2014 - 2025
    • 7.6.3 South Africa
      • 7.6.3.1 South Africa market estimates and forecast, 2014 - 2025

Chapter 8 Company Profile

  • 8.1 Abbott Laboratories
    • 8.1.1 Company overview
    • 8.1.2 Financial performance
    • 8.1.3 Product benchmarking
    • 8.1.4 Strategic initiatives
  • 8.2 Roche Diagnostics
    • 8.2.1 Company overview
    • 8.2.2 Financial performance
    • 8.2.3 Product benchmarking
    • 8.2.4 Strategic initiatives
  • 8.3 Qiagen
    • 8.3.1 Company overview
    • 8.3.2 Financial performance
    • 8.3.3 Product benchmarking
    • 8.3.4 Strategic initiatives
  • 8.4 Siemens Healthineers
    • 8.4.1 Company overview
    • 8.4.2 Financial performance
    • 8.4.3 Product benchmarking
    • 8.4.4 Strategic initiatives
  • 8.5 Thermo Fischer Scientific Inc.
    • 8.5.1 Company overview
    • 8.5.2 Financial performance
    • 8.5.3 Product benchmarking
    • 8.5.4 Strategic initiatives
  • 8.6 Hologic
    • 8.6.1 Company overview
    • 8.6.2 Financial performance
    • 8.6.3 Product benchmarking
    • 8.6.4 Strategic initiatives
  • 8.7 Becton, Dickinson and Company
    • 8.7.1 Company overview
    • 8.7.2 Financial performance
    • 8.7.3 Product benchmarking
    • 8.7.4 Strategic initiatives
  • 8.8 Sirtex Medical ltd.
    • 8.8.1 Company overview
    • 8.8.2 Financial performance
    • 8.8.3 Product benchmarking
    • 8.8.4 Strategic initiatives
  • 8.9 Koninklijke Philips N.V.
    • 8.9.1 Company overview
    • 8.9.2 Financial performance
    • 8.9.3 Product benchmarking
    • 8.9.4 Strategic initiatives
  • 8.10 Illumina,Inc.
    • 8.10.1 Company overview
    • 8.10.2 Financial performance
    • 8.10.3 Product benchmarking
    • 8.10.4 Strategic initiatives
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.